ImmuCell Corporation (ICCC) vs Nutriband Inc. (NTRB)
A side-by-side comparison of ImmuCell Corporation and Nutriband Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCC
ImmuCell Corporation
$9.75HealthcareDelayed quote: Oct 6, 2026, 1:29 PM EDT
NTRB
Nutriband Inc.
$6.60HealthcareDelayed quote: Oct 6, 2026, 1:24 PM EDT
Total return — ICCC vs NTRB
growth of $100 · dividends reinvested · last 5yICCC +4.2% (+0.8%/yr)NTRB +30.1% (+5.4%/yr)NTRB compounded faster over this window
ICCC NTRB
ICCC vs NTRB: by the numbers
- •ICCC is the larger company ($88M vs $80M market cap).
- •ICCC is profitable (2.57% net margin) while NTRB runs a net loss (-430.43%).
- •ICCC grew revenue faster over the past five years (13.74% vs 3.12% CAGR).
Metrics side by side
Valuation
| Metric | ICCC | NTRB |
|---|---|---|
| P/E ratio | 115.25 | N/A |
| Forward P/E | N/A | 4.20 |
| P/S ratio | 2.88 | 49.60 |
| P/B ratio | 2.81 | 15.06 |
| EV / EBITDA | 14.69 | N/A |
| FCF yield | 4.78% | N/A |
Profitability
| Metric | ICCC | NTRB |
|---|---|---|
| Gross margin | 40.32% | 33.14% |
| Operating margin | 12.60% | -408.41% |
| Net margin | 2.57% | -430.43% |
| ROE | 2.51% | -130.67% |
| ROIC | 8.16% | -126.99% |
Growth (annualized)
| Metric | ICCC | NTRB |
|---|---|---|
| Revenue CAGR (5Y) | 13.74% | 3.12% |
| Total return CAGR (5Y) | 0.65% | 6.67% |
Frequently asked
- Which has grown faster, ICCC or NTRB?
- Over the past five years, ICCC grew revenue faster — ICCC at a 13.74% CAGR versus NTRB at 3.12%.
- Is ICCC or NTRB more profitable?
- ICCC runs the higher net margin — ICCC at 2.57% versus NTRB at -430.43%.
- How have ICCC and NTRB total returns compared?
- Over the past 5 years, ICCC delivered 0.65% and NTRB delivered 6.67% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioImmuCell ROENutrib ROEImmuCell operating marginNutrib operating marginImmuCell revenue growthNutrib revenue growthImmuCell free cash flowNutrib free cash flow
ImmuCell & Nutrib appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.